Ticagrelor monotherapy beyond 1 month versus standard dual antiplatelet therapy after drug-eluting coronary stenting: a pre-specified per-protocol analysis of the GLOBAL LEADERS trial

Authors: F Gragnano, M Zwahlen, P Vranckx, P Juni, D Heg, C Hamm, P.G Steg, N Hagenbuch, G Gargiulo, R.J Van Geuns, K Huber, R Van Amsterdam, P.W Serruys, M Valgimigli, S Windecker

Published: 2020-11-26

DOI: 10.1093/ehjci/ehaa946.2577

Source: Full article

Ticagrelor monotherapy beyond 1 month versus standard dual antiplatelet therapy after drug-eluting coronary stenting: a pre-specified per-protocol analysis of the GLOBAL LEADERS trial

Abstract